Table 1 Participant demographic characteristics and select baseline measures in the mITT analysis set.

From: Differential treatment response to virtual reality in high-impact chronic pain: secondary analysis of a randomized trial

 

RelieVRx: LICP (n = 344)

RelieVRx: HICP (n = 192)

P

Gender

   

Female

253 (73.5)

158 (82.3)

0.025

Male

90 (26.2)

34 (17.7)

 

Non-binary

1 (0.3)

0 (0.0)

 

Race and Ethnicity

  

0.005

American Indian/Alaska Native

3 (0.9)

1 (0.5)

 

Asian/Pacific Islander

7 (2.0)

5 (2.6)

 

Black/African American

34 (9.9)

47 (24.5)

 

Caucasian

260 (75.6)

110 (57.3)

 

Hispanic/Latin

11 (3.2)

7 (3.6)

 

Multiracial

29 (8.4)

22 (11.5)

 

Age (y)

50.9 (14.2)

49.5 (11.9)

0.23

Household Annual Income

  

0.0001

 < $60,000

181 (52.5)

133 (69.4)

 

 ≥ $60,000

163 (47.5)

59 (30.6)

 

Number of Pain Comorbidities

  

0.52

0

140 (40.7)

75 (39.1)

 

 ≥ 1

182 (52.9)

110 (57.3)

 

Non reported

22 (6.4)

7 (3.6)

 

Body mass index

30.4 (7.7)

33.9 (17.8)

0.01

BPI Pain Intensity

5.9 (1.2)

7.9 (1.0)

 < 0.0001

BPI Pain Interference

5.2 (1.4)

8.1 (0.8)

 < 0.0001

PROMIS Anxiety

55.1 (8.8)

57.9 (9.5)

 < 0.0001

PROMIS Sleep Disturbance

58.7 (6.7)

64.4 (6.5)

 < 0.0001

PROMIS Depression

54.0 (8.6)

56.7 (10.2)

0.002

Oswestry Disability Index (ODI)

36.0 (13.2)

51.3 (14.7)

 < 0.0001

  1. Note: Data are presented as n (%) or mean (SD). P-value from t-test or Fisher’s exact test comparing LICP to HICP.